Wolters Kluwer LWW High Impact Journal Collection

Name: Wolters Kluwer LWW High Impact Journal Collection
Brand: Wolters Kluwer

Wolters Kluwer LWW High Impact Journal Collection is an institutional e-journal package that delivers full-text access to more than 70 Lippincott peer-reviewed medical and healthcare journals through the Ovid platform, with integrated search, alerting, and linking features.

Est 1836|Valuation $19.4B|Raised $840K

LinkedIn 357K|Website|Web traffic 3.0M|FTEs 21,000|HQ Alphen aan den Rijn, Netherlands

Wolters Kluwer LWW High Impact Journal Collection screenshot

01Competitive Landscape

Narrative analysis

Where the LWW High Impact package can be operationally advantageous: - Institutions already using Ovid (for example, Ovid MEDLINE or Embase) may reduce contextual switching by consolidating LWW content within the same platform. - A curated set of LWW titles can be a pragmatic option for institutions that require a clinical core without adopting a much larger multi-publisher mega-bundle. Where competitors may be stronger: - Large multidisciplinary collections from Elsevier, Springer, or Wiley may better serve universities with extensive basic science and cross-disciplinary needs. - BMJ packages may better align with institutions that prioritize BMJ’s evidence-based titles and editorial approach. - Discovery-first approaches (EBSCO, Ex Libris) improve cross-publisher discoverability but do not replace the need for licensed full-text access. Pricing comparison reality: - Major scholarly publishers and platform providers typically use quote-based institutional licensing. Practical differentiation is often driven by negotiation leverage, consortial arrangements, and measured cost-per-use.

	LWW High Impact Journal Collection (via Ovid)	Elsevier (e.g., ClinicalKey / ScienceDirect collections)	BMJ Journals package
Starting Price	Quote-based institutional licensing (non-public)	Quote-based institutional licensing (varies by product/institution)	Quote-based institutional licensing (typical for packages)
Most suitable for	Institutions that require a consolidated set of LWW titles and use Ovid workflows	Institutions with extensive reliance on Elsevier content and integrated clinical reference needs	Institutions prioritizing BMJ editorial content and evidence-based titles
Key strength	Integration with Ovid search and centralized access to LWW titles	Large content breadth and mature platform ecosystem	Well-known BMJ editorial portfolio and focused journal list
Key weakness	Non-transparent pricing; coverage limited to LWW titles; dependent on Ovid access model	Potential exclusion of society-controlled titles; licensing complexity and potential cost	May not align with specialty needs outside BMJ coverage; licensing and OA/APC variability

01Competitive Landscape

Narrative analysis

Where the LWW High Impact package can be operationally advantageous:

Institutions already using Ovid (for example, Ovid MEDLINE or Embase) may reduce contextual switching by consolidating LWW content within the same platform.
A curated set of LWW titles can be a pragmatic option for institutions that require a clinical core without adopting a much larger multi-publisher mega-bundle.

Where competitors may be stronger:

Large multidisciplinary collections from Elsevier, Springer, or Wiley may better serve universities with extensive basic science and cross-disciplinary needs.
BMJ packages may better align with institutions that prioritize BMJ’s evidence-based titles and editorial approach.
Discovery-first approaches (EBSCO, Ex Libris) improve cross-publisher discoverability but do not replace the need for licensed full-text access.

Pricing comparison reality:

Major scholarly publishers and platform providers typically use quote-based institutional licensing. Practical differentiation is often driven by negotiation leverage, consortial arrangements, and measured cost-per-use.

	LWW High Impact Journal Collection (via Ovid)	Elsevier (e.g., ClinicalKey / ScienceDirect collections)	BMJ Journals package
Starting Price	Quote-based institutional licensing (non-public)	Quote-based institutional licensing (varies by product/institution)	Quote-based institutional licensing (typical for packages)
Most suitable for	Institutions that require a consolidated set of LWW titles and use Ovid workflows	Institutions with extensive reliance on Elsevier content and integrated clinical reference needs	Institutions prioritizing BMJ editorial content and evidence-based titles
Key strength	Integration with Ovid search and centralized access to LWW titles	Large content breadth and mature platform ecosystem	Well-known BMJ editorial portfolio and focused journal list
Key weakness	Non-transparent pricing; coverage limited to LWW titles; dependent on Ovid access model	Potential exclusion of society-controlled titles; licensing complexity and potential cost	May not align with specialty needs outside BMJ coverage; licensing and OA/APC variability

Wolters Kluwer LWW High Impact Journal Collection

01Competitive Landscape

Narrative analysis

02Market Map

01Competitive Landscape

Narrative analysis

02Market Map